Works matching DE "PROSTACYCLIN derivatives"
Results: 30
The effects of iloprost and alprostadil on ischemia-reperfusion injury in preventing inflammation, tissue degeneration, and apoptosis in rat skeletal muscle.
- Published in:
- Turkish Journal of Medical Sciences, 2017, v. 47, n. 3, p. 1028, doi. 10.3906/sag-1604-59
- By:
- Publication type:
- Article
Therapy for Pulmonary Arterial Hypertension: The More, the Merrier?
- Published in:
- Annals of Internal Medicine, 2008, v. 149, n. 8, p. 583, doi. 10.7326/0003-4819-149-8-200810210-00010
- By:
- Publication type:
- Article
Prognostic Aspects of TcPo[sub2] in Iloprost Treatment as an Alternative to Amputation.
- Published in:
- Angiology, 1999, v. 50, n. 4, p. 283, doi. 10.1177/000331979905000403
- By:
- Publication type:
- Article
Effectiveness of therapy with iloprost in hand–arm vibration syndrome.
- Published in:
- Occupational Medicine, 2004, v. 54, n. 4, p. 261, doi. 10.1093/occmed/kqh035
- By:
- Publication type:
- Article
The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia.
- Published in:
- Journal of Microencapsulation, 2012, v. 29, n. 3, p. 211, doi. 10.3109/02652048.2011.622054
- By:
- Publication type:
- Article
Prostacyclin Reduces Symptoms and Sympathetic Dysfunction in Erythromelalgia in a Double-blind Randomized Pilot Study.
- Published in:
- 2003
- By:
- Publication type:
- Report
Hepatic O2 exchange and liver energy metabolism in hyperdynamic porcine endotoxemia: effects of iloprost.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1.
- Published in:
- Scientific Reports, 2015, p. 17376, doi. 10.1038/srep17376
- By:
- Publication type:
- Article
Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results.
- Published in:
- Rheumatology International, 2006, v. 26, n. 4, p. 340, doi. 10.1007/s00296-004-0563-9
- By:
- Publication type:
- Article
Elucidating the Structure-Activity Relationships of the Vasorelaxation and Antioxidation Properties of Thionicotinic Acid Derivatives.
- Published in:
- Molecules, 2010, v. 15, n. 1, p. 198, doi. 10.3390/molecules15010198
- By:
- Publication type:
- Article
Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2b PILOT Study.
- Published in:
- European Journal of Clinical Investigation, 2013, v. 43, n. 11, p. 1163, doi. 10.1111/eci.12159
- By:
- Publication type:
- Article
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2013, v. 3, n. 1, p. 116, doi. 10.4103/2045-8932.109926
- By:
- Publication type:
- Article
Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
- Published in:
- Pulmonary Circulation, 2011, v. 1, n. 1, p. 33, doi. 10.4103/2045-8932.78101
- By:
- Publication type:
- Article
TARGETING THE PROSTACYCLIN/PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AXIS IN LUNG CANCER CHEMOPREVENTION.
- Published in:
- Transactions of the American Clinical & Climatological Association, 2018, v. 129, p. 48
- By:
- Publication type:
- Article
Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function.
- Published in:
- Journal of Clinical Investigation, 2007, v. 117, n. 2, p. 464, doi. 10.1172/JCI28949
- By:
- Publication type:
- Article
Iloprost infusion does not reduce oxidative stress in systemic sclerosis.
- Published in:
- Rheumatology International, 2008, v. 28, n. 4, p. 335, doi. 10.1007/s00296-007-0443-1
- By:
- Publication type:
- Article
Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069302
- By:
- Publication type:
- Article
The Role of Targeted Therapies in the Management of Pulmonary Arterial Hypertension.
- Published in:
- Current Medical Literature: Respiratory Medicine, 2009, v. 23, n. 3, p. 57
- By:
- Publication type:
- Article
A randomized trial of iloprost in patients with intermittent claudication.
- Published in:
- Vascular Medicine, 2008, v. 13, n. 1, p. 5, doi. 10.1177/1358863X07084910
- By:
- Publication type:
- Article
Is intravenous Iloprost better than oral nifedipine in systemic sclerosis?
- Published in:
- 1989
- By:
- Publication type:
- Abstract
Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients.
- Published in:
- Rheumatology, 2007, v. 46, n. 9, p. 1460, doi. 10.1093/rheumatology/kem172
- By:
- Publication type:
- Article
A curious but non-serious local side effect of inhaled iloprost: sudden linear erythematous facial rash.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Inhaled Iloprost: A Viewpoint by Nazzareno Galiè.
- Published in:
- Drugs, 2004, v. 64, n. 7, p. 774, doi. 10.2165/00003495-200464070-00010
- By:
- Publication type:
- Article
Inhaled Iloprost: A Viewpoint by J. Simon R. Gibbs.
- Published in:
- Drugs, 2004, v. 64, n. 7, p. 774, doi. 10.2165/00003495-200464070-00011
- By:
- Publication type:
- Article
Inhaled Iloprost: A Viewpoint by Tine L.M. De Backer.
- Published in:
- Drugs, 2004, v. 64, n. 7, p. 774, doi. 10.2165/00003495-200464070-00012
- By:
- Publication type:
- Article
Inhaled Iloprost: In Primary Pulmonary Hypertension.
- Published in:
- Drugs, 2004, v. 64, n. 7, p. 763, doi. 10.2165/00003495-200464070-00009
- By:
- Publication type:
- Article
Reducing error in feline platelet enumeration by addition of Iloprost to blood specimens: comparison to prostaglandin E1 and EDTA.
- Published in:
- Veterinary Clinical Pathology, 2015, v. 44, n. 2, p. 179, doi. 10.1111/vcp.12247
- By:
- Publication type:
- Article
Microcirculatory Effects of Iloprost in Patients with Suspected Secondary Raynaud Phenomenon.
- Published in:
- Vascular Surgery, 1995, v. 29, n. 1, p. 37, doi. 10.1177/153857449502900105
- By:
- Publication type:
- Article
Iloprost, a Prostacyclin Analog in the Treatment of Advanced Peripheral Arterial Disease.
- Published in:
- Vascular Surgery, 1986, v. 20, n. 5, p. 301, doi. 10.1177/153857448602000504
- By:
- Publication type:
- Article